Revolutionize care for people and planet
Transforming care for patients and caregivers
At Mölnlycke, we have always been dedicated to improving quality of life for patients and those who care for them. We do it by offering innovative, high-quality solutions for wound care and surgical procedures, and by helping you implement new and better ways of working. Ultimately, we enable safer, more efficient and sustainable care. For people and planet.
Latest updates
Discover our latest offers and campaigns.
Let's make room for what matters
There are many examples of non-value added tasks, in or around the OR, that could easily be eliminated, simply by implementing more efficient ways of working.
Read more-
Find the right antiseptic product
Our antiseptic products are gentle on the skin, provides persistent antimicrobial protection and offers effective cleansing without leaving a sticky residue.
Read more -
Introducing the new Mepilex® Up:
An innovative foam dressing designed for exuding wounds.
Read more
‘I always double-glove, and have from the very beginning. It's never been a challenge to work this way.’
David Revez Neurosurgeon
Get in touch
We're here to help
If you have any questions about our products and solutions or need assistance, contact our sales team. We look forward to helping you find the perfect solution for your needs.
Contact usLatest news
Read all news-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
-
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.
-
EUR bond issue and tender announcement
Mölnlycke intends to issue a new 10-year EUR bond and launches a tender offer for the outstanding EUR 500m bond due February 2025.
-
Mölnlycke signs a EUR 350 million revolving credit facility
On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility. The facility has a tenor of five years with two one-year extension options and will be used as a backup for general corporate purposes. The facility is a refinancing of the existing and undrawn revolving credit facility signed in 2017.
-
Mölnlycke Health Care agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturizing.
-
Mölnlycke announces new partnership with burn survivors organisation Phoenix Society
Mölnlycke Health Care is pleased to announce our partnership with Phoenix Society for Burn Survivors.
-
In 2023 Mölnlycke was awarded a gold medal for Sustainability by EcoVadis
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a gold medal for our focus on sustainability. They have ranked us in the top 3% of companies worldwide.
-
Mölnlycke integrated Annual Report 2023
Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and planet contributed to a very successful year with record high annual net sales of EUR 1,924 million and substantial improvements in profitability. We continue to report our sustainability achievements in accordance with the Global Reporting Initiative (GRI) standards.